Berkshire Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-153,810
| Closed | -$692K | – | 288 |
|
|
2025
Q1 | $692K | Buy |
+153,810
| New | +$692K | 0.03% | 163 |
|
|
2022
Q3 | – | Sell |
-189,048
| Closed | -$392K | – | 220 |
|
|
2022
Q2 | $392K | Buy |
189,048
+6,907
| +4% | +$14.3K | 0.03% | 159 |
|
|
2022
Q1 | $514K | Hold |
182,141
| – | – | 0.03% | 137 |
|
|
2021
Q4 | $851K | Buy |
182,141
+5,956
| +3% | +$27.8K | 0.05% | 128 |
|
|
2021
Q3 | $472K | Buy |
176,185
+5,355
| +3% | +$14.3K | 0.03% | 169 |
|
|
2021
Q2 | $486K | Buy |
170,830
+5,335
| +3% | +$15.2K | 0.03% | 160 |
|
|
2021
Q1 | $501K | Hold |
165,495
| – | – | 0.04% | 151 |
|
|
2020
Q4 | $488K | Buy |
+165,495
| New | +$488K | 0.04% | 148 |
|
|
2020
Q2 | – | Sell |
-164,495
| Closed | -$597K | – | 177 |
|
|
2020
Q1 | $597K | Buy |
+164,495
| New | +$597K | 0.06% | 120 |
|
|
2013
Q4 | – | Sell |
-28,100
| Closed | -$127K | – | 168 |
|
|
2013
Q3 | $127K | Sell |
28,100
-900
| -3% | -$4.07K | 0.03% | 137 |
|
|
2013
Q2 | $148K | Buy |
+29,000
| New | +$148K | 0.04% | 119 |
|